Wednesday, October 10, 2012 Tuesday, October 9, 2012- 1 Pharma Receiving Nice Newsat Motley Fool (Tue, Oct 9)
- Bad News For Pharma In World's Second-Biggest Marketat Forbes (Tue, Oct 9)
- Stock's Up 20% on Hope From a Failed Trialat Motley Fool (Tue, Oct 9)
- Johnson & Johnson vs. Goldman & Goldman: Street Whispersat TheStreet (Tue, Oct 9)
- Is Pfizer’s Stock a Buy Now?at Wall St. Cheat Sheet (Tue, Oct 9)
- Pfizer's Strategies Make Investment Appealingat Seeking Alpha (Tue, Oct 9)
- Cancer Stem Cell Therapy: Real Or Just Hype?at Forbes (Tue, Oct 9)
- Pfizer Inc Stock Buy Recommendation Reiterated (PFE)at TheStreet (Tue, Oct 9)
- Lilly Up on Alzheimer's DataZacks (Tue, Oct 9)
- Healthcare Business Report: Pfizer’s SEC Inquiry, Exact Science’s Potentialat Wall St. Cheat Sheet (Tue, Oct 9)
- The Zacks Analyst Blog Highlights: GlaxoSmithKline, Pfizer, Theravance, Amicus Therapeutics and Parker-HannifinZacks (Tue, Oct 9)
- A step forward on Alzheimer's, maybeat bizjournals.com (Tue, Oct 9)
- Nobel Winner’s Stem Cells to Be Tested in Eye Malady in 2013at Bloomberg (Tue, Oct 9)
Monday, October 8, 2012Add PFE News to My Yahoo!  | |
|